Robert Mannel to Mitogen-Activated Protein Kinase Kinases
This is a "connection" page, showing publications Robert Mannel has written about Mitogen-Activated Protein Kinase Kinases.
Connection Strength
0.105
-
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study. Lancet Oncol. 2013 Feb; 14(2):134-40.
Score: 0.105
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.